Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous nicardipine versus esmolol effects on coronary shear stress in unstable angina
ChiCTR-TRC-10000964Phase 4Completed
- Sponsor
- Nanjing First Hospital
- Start
- Oct 2010
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in acute coronary syndrome (ACS) and unstable angina comparing Esmolol group with Nicardipine group (2 arms). Primary endpoints: Change in coronary blood flow velocity and Redistribution of coronary endothelial shear stress. Started Oct 2010; status: completed.
02
Drugs
nicardipineesmolol
03
Conditions
acute coronary syndrome (ACS)unstable angina
Beyond the preview
Go deeper on ChiCTR-TRC-10000964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000964.